[1] |
邓银芝,黄铁军,张明哲,等. 非酒精性脂肪肝病患者血清PTX3水平与胰岛素抵抗以及氧化应激相关分析[J]. 中国肝脏病杂志(电子版),2015,7(2):101-105.
|
[2] |
黄召武. 2型糖尿病合并非酒精性脂肪肝患者氧化应激、炎性因子和硫氧还蛋白水平的检测价值[J]. 华夏医学,2019,32(1):7-9.
|
[3] |
ABDELBASSET W K,TANTAWY S A,KAMEL D M,et al.Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease:a comparative randomized controlled trial[J]. Medicine(Baltimore),2020,99(10):e19471.
|
[4] |
陆雷群,张叶丽,沈莹,等. 肝纤维化指标对2型糖尿病合并非酒精性脂肪肝患者的早期临床诊断意义的研究[J]. 海南医学院学报,2019,25(13):974-978.
|
[5] |
范建高. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 胃肠病学和肝病学杂志,2010,19(6):483-487.
|
[6] |
LUUKKONEN P K,DUFOUR S,LYU K,et al.Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease[J]. Proc Natl Acad Sci U S A,2020,117(13):7347-7354.
|
[7] |
刘阳,文涛,于世家. 2型糖尿病合并非酒精性脂肪肝患者临床特征及相关危险因素研究[J]. 中国卫生统计,2016,33(1):105-106.
|
[8] |
杨智才. 血清TBA、AST、ALT与AST/ALT联合检测在诊断急性肝炎中的应用价值[J]. 当代医药论丛,2019,17(15):167-168.
|
[9] |
王玉莲. 血脂血糖和肝功能检测对非酒精性脂肪肝患者临床意义分析[J]. 现代诊断与治疗,2018,29(11):1753-1755.
|
[10] |
郭红智. 非酒精性脂肪肝患者血脂、血糖及肝功能检验的价值[J]. 中国医药指南,2016,14(11):175-176.
|
[11] |
KALINOWSKI P,PALUSZKIEWICZ R,ZIARKIEWICZ-WRÓBLEWSKA B,et al. Liver function in patients with nonalcoholic fatty liver disease randomized to roux-en-Y gastric bypass versus sleeve gastrectomy:a secondary analysis of a randomized clinical trial[J]. Ann Surg,2017,266(5):738-745.
|
[12] |
NEGRI R,TRINCHESE G,CARBONE F,et al.Randomised clinical trial:calorie restriction regimen with tomato juice supplementation ameliorates oxidative stress and preserves a proper immune surveillance modulating mitochondrial bioenergetics of T-lymphocytes in obese children affected by non-alcoholic fatty liver disease(NAFLD)[J]. J Clin Med,2020,9(1):141.
|
[13] |
谈力欣,刘焱,张秀云,等. 2型糖尿病合并非酒精性脂肪肝患者炎性因子、氧化应激、硫氧还蛋白互作蛋白水平研究及相关性分析[J]. 河北医药,2018,40(9):1285-1289.
|
[14] |
DWIVEDI D K,JENA G B.NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat:studies on oxidative stress,inflammation,DNA damage and insulin signalling pathway[J]. Naunyn Schmiedebergs Arch Pharmacol,2020,393(4):705-716.
|
[15] |
WIDERSKA M,MACIEJCZYK M,ZALEWSKA A,et al.Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease(NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients[J]. Free Radic Res,2019,53(8):841-850.
|